- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: moderate tricispid
Total 5846 results
-
SanofiCompletedErectile DysfunctionFrance
-
Azienda Sanitaria Locale 4, TeramoUnknown
-
Chiesi Farmaceutici S.p.A.Terminated
-
PfizerCompletedAlzheimer DiseaseGreece
-
Hadassah Medical OrganizationUnknownTraumatic Brain InjuryIsrael
-
Novartis PharmaceuticalsCompletedOnychomycosisUnited States, France, Germany
-
TakedaCompletedHypertensionUnited States, Argentina, Peru, Mexico
-
Novartis PharmaceuticalsCompleted
-
Bristol-Myers SquibbSanofiCompletedHypertensionUnited States, Canada, Germany, Russian Federation, France
-
AbbottCompletedPsoriasisUnited States, Austria, Belgium, Canada, France, Germany, Poland, Puerto Rico, Spain, Switzerland
-
AbbottCompletedChronic Plaque PsoriasisBelgium, Denmark, France, Germany, Spain, Sweden, Switzerland, Finland, Turkey, Italy, Czech Republic, Austria, Netherlands, United Kingdom, Greece
-
AbbottCompletedUlcerative ColitisUnited States, Austria, Belgium, Canada, Czech Republic, Germany, Hungary, Italy, Netherlands, Poland, Puerto Rico, Slovakia, Sweden
-
SanofiBristol-Myers SquibbCompleted
-
Eisai Inc.PfizerCompletedAlzheimer's DiseaseUnited States
-
University of CincinnatiUnknown
-
Bispebjerg HospitalDanish Lung Association; Sygekassernes Helsefond; Ministry of the Interior and...CompletedChronic Obstructive Pulmonary Disease
-
Rush University Medical CenterAstellas Pharma US, Inc.CompletedAtopic DermatitisUnited States
-
TD Vaccines A/SJohns Hopkins Bloomberg School of Public Health; Pierrel Research USA, Inc.Completed
-
Creabilis SACompleted
-
AstraZenecaCompletedAlzheimer's DiseasePeru, Poland, Canada, South Africa
-
TakedaCompleted
-
Janssen Pharmaceutica N.V., BelgiumCompletedConduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder
-
Janssen Pharmaceutica N.V., BelgiumCompletedConduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AbbottCompletedModerate to Severe Chronic, Non-malignant PainUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedIn Development for Cystic FibrosisCzech Republic, Slovakia
-
Nuon Therapeutics, Inc.CompletedHyperuricemia | Moderate to Severe GoutUnited States
-
Weill Medical College of Cornell UniversityUnknownDiabetes Mellitus, Type 2United States
-
Goldman, Butterwick, Fitzpatrick and GroffMentor Worldwide, LLCUnknown
-
University of North Carolina, Chapel HillNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Christiana Care Health ServicesCompleted
-
Zurita Laboratorio Farmaceutico Ltda.UnknownTreatment of Acne Vulgaris Grade II in a Short Period of Time.Brazil
-
Sankyo Pharma GmbhCompletedEssential HypertensionFrance, Austria, Switzerland, Belgium, Germany, Italy, Netherlands, United Kingdom, Portugal
-
Technical University of MunichCompleted
-
PfizerCompleted
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Sweden, Denmark, Finland, Netherlands, Norway
-
AstraZenecaCompletedModerate/Severe AsthmaRomania
-
Hospital Universitari Son DuretaEspen; This research prize was funded by Nestle Nutrition Institute and by...CompletedModerate to Severe Trauma, as Defined by an | Injury Severity Score (ISS) > 12 Points Were Included in the Study.Spain